Athenex, Inc. (ATNX) Social Stream



Athenex, Inc. (ATNX): $0.96

0.33 (+51.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About ATNX

$ATNX
Oraxol - potential we see a boost in Q4 if ATNX announces that the new study is to be of a shorter duration focused more on safety than on outcome. This would be good news because I expect that the neutropenia will not be an issue with US patients who are given drugs to boost blood counts.

Klisyri - unfortunately no one cares about this drug. Maybe if they unexpectedly announce killer sales by Q4 we will see a boost.

Other pipeline - IMO this is where we have the most potential to see a rise in share price. If ATNX announces positive phase 1 or phase 2 data on any of their products, especially KUR502 which is used to treat leukemia/lymphoma (which is a much bigger market than neuroblastoma for KUR501 or angiosarcoma for Oraxol).

I'm still holding hoping we see some good data. Would like to exit my position completely near 5.0.
boblo9, published August 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4138 seconds.